212 related articles for article (PubMed ID: 35428798)
1. Imaging of the medial rectus muscle predicts the development of optic neuropathy in thyroid eye disease.
Berger M; Matlach J; Pitz S; Berres M; Axmacher F; Kahaly GJ; Brockmann MA; Müller-Eschner M
Sci Rep; 2022 Apr; 12(1):6259. PubMed ID: 35428798
[TBL] [Abstract][Full Text] [Related]
2. Visual field and orbital computed tomography correlation in dysthyroid optic neuropathy due to thyroid eye disease.
Starks VS; Reinshagen KL; Lee NG; Freitag SK
Orbit; 2020 Apr; 39(2):77-83. PubMed ID: 31057005
[No Abstract] [Full Text] [Related]
3. Quantitative computed tomographic predictors of compressive optic neuropathy in patients with thyroid orbitopathy: a volumetric analysis.
Weis E; Heran MK; Jhamb A; Chan AK; Chiu JP; Hurley MC; Rootman J
Ophthalmology; 2012 Oct; 119(10):2174-8. PubMed ID: 22709420
[TBL] [Abstract][Full Text] [Related]
4. Measurement of Medial Wall Bowing and Clinical Associations in Thyroid Eye Disease.
Bokman CL; Ugradar S; Rootman DB
Ophthalmic Plast Reconstr Surg; 2018; 34(6):557-559. PubMed ID: 29505466
[TBL] [Abstract][Full Text] [Related]
5. Extraocular muscle volume index at the orbital apex with optic neuritis: a combined parameter for diagnosis of dysthyroid optic neuropathy.
Song C; Luo Y; Huang W; Duan Y; Deng X; Chen H; Yu G; Huang K; Xu S; Lin X; Wang Y; Shen J
Eur Radiol; 2023 Dec; 33(12):9203-9212. PubMed ID: 37405499
[TBL] [Abstract][Full Text] [Related]
6. Radiologic Parameters of Orbital Bone Remodeling in Thyroid Eye Disease.
Tan NYQ; Leong YY; Lang SS; Htoon ZM; Young SM; Sundar G
Invest Ophthalmol Vis Sci; 2017 May; 58(5):2527-2533. PubMed ID: 28492870
[TBL] [Abstract][Full Text] [Related]
7. Teprotumumab reduces extraocular muscle and orbital fat volume in thyroid eye disease.
Jain AP; Gellada N; Ugradar S; Kumar A; Kahaly G; Douglas R
Br J Ophthalmol; 2022 Feb; 106(2):165-171. PubMed ID: 33172865
[TBL] [Abstract][Full Text] [Related]
8. Graves ophthalmopathy: the bony orbit in optic neuropathy, its apical angular capacity, and impact on prediction of risk.
Chan LL; Tan HE; Fook-Chong S; Teo TH; Lim LH; Seah LL
AJNR Am J Neuroradiol; 2009 Mar; 30(3):597-602. PubMed ID: 19147718
[TBL] [Abstract][Full Text] [Related]
9. Extraocular muscle enlargement in dysthyroid optic neuropathy.
Rana K; Garg D; Yong LSS; Macri C; Tong JY; Patel S; Slattery J; Chan WO; Davis G; Selva D
Can J Ophthalmol; 2023 Dec; ():. PubMed ID: 38114063
[TBL] [Abstract][Full Text] [Related]
10. Radiographic analysis of fatty infiltration of the extraocular muscles in thyroid eye disease.
Cohen LM; Liou VD; Cunnane ME; Yoon MK
Orbit; 2022 Feb; 41(1):53-58. PubMed ID: 32878536
[TBL] [Abstract][Full Text] [Related]
11. Advances in the Treatment of Thyroid Eye Disease Associated Extraocular Muscle Myopathy and Optic Neuropathy.
Lu TJ; Amarikwa L; Sears CM; Kossler AL
Curr Neurol Neurosci Rep; 2022 Jun; 22(6):313-325. PubMed ID: 35614367
[TBL] [Abstract][Full Text] [Related]
12. Orbital MRI 3D Reconstruction Based on Volume Rendering in Evaluating Dysthyroid Optic Neuropathy.
Zhang T; Chen R; Ye H; Xiao W; Yang H
Curr Eye Res; 2022 Aug; 47(8):1179-1185. PubMed ID: 35603927
[TBL] [Abstract][Full Text] [Related]
13. Combination Model of Thyrotrophin Receptor Antibody and Volumetric Orbital Apex Crowding Index as an Indicator of Dysthyroid Optic Neuropathy.
Deng Z; Chen L; Tan J; Wang S; Liu D; Wang J; Jiang C; Yang J; Xu B
Dis Markers; 2021; 2021():9964232. PubMed ID: 34113406
[TBL] [Abstract][Full Text] [Related]
14. Predicting dysthyroid optic neuropathy using computed tomography volumetric analyses of orbital structures.
Gonçalves AC; Silva LN; Gebrim EM; Matayoshi S; Monteiro ML
Clinics (Sao Paulo); 2012 Aug; 67(8):891-6. PubMed ID: 22948455
[TBL] [Abstract][Full Text] [Related]
15. The diagnostic value of the IDEAL-T2WI sequence in dysthyroid optic neuropathy: a quantitative analysis of the optic nerve and cerebrospinal fluid in the optic nerve sheath.
Wu H; Luo B; Yuan G; Wang Q; Liu P; Zhao Y; Zhai L; Ma Y; Lv W; Zhang J
Eur Radiol; 2021 Oct; 31(10):7419-7428. PubMed ID: 33993334
[TBL] [Abstract][Full Text] [Related]
16. Clinical and soft-tissue computed tomographic predictors of dysthyroid optic neuropathy: refinement of the constellation of findings at presentation.
Weis E; Heran MK; Jhamb A; Chan AK; Chiu JP; Hurley MC; Rootman J
Arch Ophthalmol; 2011 Oct; 129(10):1332-6. PubMed ID: 21987676
[TBL] [Abstract][Full Text] [Related]
17. Risk prediction of dysthyroid optic neuropathy based on CT imaging features combined the bony orbit with the soft tissue structures.
Cheng S; Ming Y; Hu M; Zhang Y; Jiang F; Wang X; Xiao Z
Front Med (Lausanne); 2022; 9():936819. PubMed ID: 36091692
[TBL] [Abstract][Full Text] [Related]
18. Correlation between extraocular muscle size and motility restriction in thyroid eye disease.
Dagi LR; Zoumalan CI; Konrad H; Trokel SL; Kazim M
Ophthalmic Plast Reconstr Surg; 2011; 27(2):102-10. PubMed ID: 21383547
[TBL] [Abstract][Full Text] [Related]
19. Bony Orbital Volume Expansion in Thyroid Eye Disease.
Ugradar S; Goldberg RA; Rootman DB
Ophthalmic Plast Reconstr Surg; 2019; 35(5):434-437. PubMed ID: 30550499
[TBL] [Abstract][Full Text] [Related]
20. Asymmetric proptosis in thyroid eye disease.
Rana K; Garg D; Yong LSS; Leyden J; Patel S; Slattery J; Davis G; Chan WO; Selva D
Int Ophthalmol; 2024 Apr; 44(1):206. PubMed ID: 38678129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
